| Dr Thomas John Manley, MD | |
|
825 Eastlake Ave E, Seattle, WA 98109-4405 | |
| (206) 288-1000 | |
| Not Available |
| Full Name | Dr Thomas John Manley |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 825 Eastlake Ave E, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003998014 | NPI | - | NPPES |
| 8326712 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | MD00037488 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas John Manley, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Dr Thomas John Manley, MD 825 Eastlake Ave E, Seattle, WA 98109-4405 Ph: (206) 288-1000 |
News Archive
Today, on World Heart Day, the International Federation on Ageing (IFA) calls on all health care professionals to encourage older people and most importantly those with cardiovascular disease in their care to be vaccinated against the serious and life-altering infectious diseases of influenza and pneumonia.
It was wartime and food was scarce. Leaders of England's effort to wage war and help the public survive during World War II needed to know: Were the rations in lifeboats adequate for survival at sea? And, among several experiments important for public as well as military heath, how much vitamin C did a person need to avoid the deadly disease scurvy?
The chances of developing lung cancer associated with asbestos exposure, asbestosis and smoking are dramatically increased when these three risk factors are combined, and quitting smoking significantly reduces the risk of developing lung cancer after long-term asbestos exposure, according to a new study.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 6 days ago
Dr. James Toliver Bennett Jr., M.D., PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Genetic Medicine, Seattle, WA 98105 Phone: 206-987-2056 | |
Dr. Leslie Ann Dervan, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Mb.10.620, Seattle, WA 98105 Phone: 206-987-0293 | |
Dr. Indi Trehan, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2000 | |
Alexa Mason, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne # Oc.7830, Seattle, WA 98105 Phone: 206-987-2525 | |
Dr. Gloria A. Arand, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3530 | |
Marcella Theresia Mascher Denen, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195 Phone: 206-543-0065 | |
Elizabeth Amy Hicks, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Seattle, WA 98105 Phone: 206-987-2599 Fax: 206-987-2599 |